AVID200
Idiopathic Pulmonary Fibrosis · TGF-b Trap
Clinical trials
1
Mechanism
TGF-b Trap
Developer
Formation Biologics
Overview
AVID200 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via tgf-b trap. It appears in 1 tracked IPF clinical trial.
AVID200 clinical trials
Explore related
Medical disclaimer. This page summarizes research about AVID200 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.